1112681

Biohaven Pharmaceuticals, Inc — FEI 3010802167

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 7, 2019
Fiscal Year
2020
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
New Haven, CT (United States)

Additional Details

Sponsor, Contract Research Organization